Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

Buzz on the Bullboards: Trudeau quits, Trump gets (more) greedy

The past week has been eventful for the TSX , reflecting the broader economic and political landscape. Monday: Canada’s main stock index managed to maintain composure, registering a controlled loss following the unexpected resignation of Prime Minis...

Brianne Gardner's 2025 stock picks

As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

Lode Gold: A compelling investment opportunity for gold enthusiasts

Lode Gold (TSXV:LOD) has had a year of growth achieving one milestone after another. Despite facing a challenging market, the company has successfully raised $6M since March 2024. Now, investors have the chance to capitalize on a unique opportunity by investing in Lode ...

Advancing flagship Ishkõday Gold Project in Ontario

LAURION Mineral Exploration (TSXV:LME) . A Canadian junior mining company focused on the exploration and development of its flagship Ishkõday gold project. Located 220 km northeast of Thunder Bay, Ontario. The Market Online recently sat down with President and CEO, Cynth...

Buzz on the Bullboards: More tricks or treats this investing season?

Hallowe’en is always a spooky season, between next week’s U.S. election, the spreading battles across the globe, and the cost of living … there is plenty to be scared about. Even so, your stock portfolio need not be one of those things. ...

Leading Edge Materials: Positioning for the EU’s critical minerals push

By David Yeoman, Crux Investor Leading Edge Materials has a portfolio of critical raw materials projects in the EU, including the Norra Kärr heavy rare earths project in Sweden, the Woxna graphite mine in Sweden, and an exploration program in Romania. ...

Prospera Energy corporate update: 3 years of strategic restructuring, recovery and future growth

CALGARY, Alberta, Oct. 24, 2024 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“PEI”) (TSX.V: PEI, OTC: GXRFF, FRA: OF6B) The 2024 Prospera corporate update outlines the company’s restructuring efforts since 2021, highlighting key m...

Meeting the projected lithium and copper supply imbalance

The following is a transcription of the above video, and The Market Online has edited it for clarity . Grid Battery Metals (TSX:CELL) has built a diverse portfolio of battery metal exploration targets, including three lithium properties in Nevada. Grid also has a c...
1 2 3 4 5 6 7 8 9 10 ...